Heterocyclic compound and organic light-emitting device comprising same

US12552985B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12552985-B2
Application numberUS-202017781291-A
CountryUS
Kind codeB2
Filing dateNov 27, 2020
Priority dateDec 2, 2019
Publication dateFeb 17, 2026
Grant dateFeb 17, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present specification relates to a heterocyclic compound represented by Chemical Formula 1, and an organic light emitting device including the same.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A heterocyclic compound represented by the following Chemical Formula 1: wherein, in Chemical Formula 1, R1 to R5 are each independently hydrogen; deuterium; a halogen group; a cyano group; a substituted or unsubstituted alkyl group having 1 to 60 carbon atoms; a substituted or unsubstituted aryl group having 6 to 60 carbon atoms; or a substituted or unsubstituted heteroaryl group having 2 to 60 carbon atoms; L is a direct bond; a substituted or unsubstituted arylene group having 6 to 60 carbon atoms; or a substituted or unsubstituted heteroarylene group having 2 to 60 carbon atoms; and Z is a substituted or unsubstituted aryl group having 10 to 60 carbon atoms; or a substituted or unsubstituted phosphine oxide group, or represented by the following Chemical Formula 2; in Chemical Formula 2, X1 to X3 are each CR or N, and at least one thereof is N; R, R21 and R22 are each independently hydrogen; deuterium; a substituted or unsubstituted alkyl group having 1 to 60 carbon atoms; a substituted or unsubstituted aryl group having 6 to 60 carbon atoms; or a substituted or unsubstituted heteroaryl group having 2 to 60 carbon atoms; adjacent groups among X1 to X3, R21 and R22 may bond to each other to form a substituted or unsubstituted ring; r is an integer of 0 to 3; a and b are each an integer of 1 to 5; and when r, a and b are each 2 or greater, substituents in the parentheses are the same as or different from each other. 2 . The heterocyclic compound of claim 1 , wherein Chemical Formula 1 is represented by any one of the following Chemical Formulae 1-1 to 1-4: in Chemical Formulae 1-1 to 1-4, each substituent has the same definition as in Chemical Formula 1. 3 . The heterocyclic compound of claim 1 , wherein Z is a substituted or unsubstituted anthracenyl group; or a phosphine oxide group unsubstituted or substituted with an alkyl group, or represented by Chemical Formula 2. 4 . The heterocyclic compound of claim 1 , wherein Chemical Formula 2 is any one selected from among the following structural formulae: in the structural formulae, R31 and R32 are each independently a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms; a substituted or unsubstituted aryl group having 6 to 60 carbon atoms; or a substituted or unsubstituted heteroaryl group having 2 to 60 carbon atoms, and R33 is hydrogen; deuterium; or a substituted or unsubstituted aryl group having 6 to 60 carbon atoms. 5 . The heterocyclic compound of claim 1 , wherein at least two of R1 to R3 are each independently a cyano group; a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms; or a substituted or unsubstituted aryl group having 6 to 20 carbon atoms. 6 . The heterocyclic compound of claim 1 , wherein Chemical Formula 1 is represented by any one of the following compounds:

Assignees

Inventors

Classifications

  • Tandem OLEDs · CPC title

  • Carrier blocking layers · CPC title

  • Electron transporting layers · CPC title

  • comprising only nitrogen as heteroatom (H10K85/652 takes precedence) · CPC title

  • comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12552985B2 cover?
The present specification relates to a heterocyclic compound represented by Chemical Formula 1, and an organic light emitting device including the same.
Who is the assignee on this patent?
Lt Materials Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07D471/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).